Smith Jodi M, Nemeth Thomas L, McDonald Ruth A
Division of Nephrology, Children's Hospital and Regional Medical Center, University of Washington, 4800 Sand Point Way, Seattle, WA 98105, USA.
Pediatr Transplant. 2004 Oct;8(5):445-53. doi: 10.1111/j.1399-3046.2004.00209.x.
Advances in immunosuppressive therapy over the past decade have led to dramatic improvements in graft survival. The immunosuppression that is used is center-dependent and is constantly evolving with the development of new medications. The goal remains to find the best combination that will optimize graft survival, while minimizing the adverse effects.
过去十年间免疫抑制疗法的进展显著提高了移植物的存活率。所采用的免疫抑制方法因中心而异，且随着新药物的研发不断演变。目标仍是找到最佳组合，在将副作用降至最低的同时，优化移植物的存活率。
